SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-12-053222
Filing Date
2012-08-01
Accepted
2012-08-01 16:11:59
Documents
12
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a12-11849_110q.htm 10-Q 1110773
2 EX-10.38 a12-11849_1ex10d38.htm EX-10.38 536302
3 EX-10.39 a12-11849_1ex10d39.htm EX-10.39 352420
4 EX-31.1 a12-11849_1ex31d1.htm EX-31.1 12910
5 EX-31.2 a12-11849_1ex31d2.htm EX-31.2 13692
6 EX-32 a12-11849_1ex32.htm EX-32 11466
  Complete submission text file 0001104659-12-053222.txt   9243549

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT thrx-20120630.xml EX-101.INS 1174969
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT thrx-20120630.xsd EX-101.SCH 70842
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT thrx-20120630_cal.xml EX-101.CAL 50274
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT thrx-20120630_lab.xml EX-101.LAB 1200732
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT thrx-20120630_pre.xml EX-101.PRE 543957
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT thrx-20120630_def.xml EX-101.DEF 390691
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30319 | Film No.: 121000239
SIC: 2834 Pharmaceutical Preparations